Early Detection and Prevention - Quality Assurance Group
The principal aim of the Quality Assurance Group (QAS) is further development and dissemination of the body of knowledge dealing with assuring the effectiveness and the appropriateness of cancer screening and complementary primary prevention strategies. Current objectives are focused on international collaboration in:
- Development and implementation of quality assurance guidelines dealing with the entire process of breast, cervical, and colorectal cancer screening, including monitoring and evaluation of service screening, and taking into account appropriate integration of primary preventive strategies, such as human papillomavirus (HPV) vaccination against cervical cancer.
- Providing scientific and technical support for planning, piloting, and implementing population-based cancer screening programmes.
- Investigation of the epidemiological significance of lesions detected in colorectal cancer screening.
- Developing international networks for the above-mentioned activities, particularly a network of competence and reference centres to facilitate training, accreditation, and certification, and to ensure that primary and secondary prevention messages are communicated effectively.